Format

Send to

Choose Destination
Alzheimers Dement (N Y). 2019 May 16;5:154-163. doi: 10.1016/j.trci.2019.03.003. eCollection 2019.

In vitro degradation of β-amyloid fibrils by microbial keratinase.

Author information

1
Department of Biochemistry, Advanced Level State Biotech Hub, Microbial Biotechnology Research Laboratory, Manipur University, Imphal, Manipur, India.
2
Department of Oral Pathology, Dental College, Regional Institute of Medical Sciences, Imphal, Manipur, India.
3
Biophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, West Bengal, India.

Abstract

Introduction:

Amyloid fibrils are misfolded, protease-resistant forms of normal proteins. They are infectious such as prions or noninfectious such as β-amyloid (Aβ) fibrils causing Alzheimer's disease (AD). Prions and amyloids are structurally similar, possessing cross β-pleated sheet-like structures. As microbial keratinase could degrade prions, we tested keratinase activity on Aβ fibrils.

Methods:

Lysozyme treated with urea generates Aβ fibrils demonstrated by immunoblotting with anti-Aβ antibody, high-performance liquid chromatography, and Congo red absorption spectroscopy. Two keratinases, Ker1 and Ker2, were purified from an actinomycete Amycolatopsis sp. MBRL 40 and incubated with Aβ fibrils.

Results:

Soluble Ker1 and Ker1 reconstituted on neutral/cationic liposomes degraded Aβ fibrils efficiently. Ker 2 was less potent.

Discussion:

Drugs that target AD inhibit acetylcholinesterase or formation of Aβ fibrils and downstream effects. These drugs have side effects and do not benefit globally in cognition. Keratinases are novel molecules for drug development against AD.

KEYWORDS:

Actinomycete; In vitro degradation; Ker 1; Keratinase; β-amyloid fibrils

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center